Figures computed from official regulatory filings — .
Ownershipinsiders 1.02% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NUTRA PHARMA CORP only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin/Nyloxin Extra Strength, an over-the-counter (OTC) pain reliever; Pet Pain-Away, a homeopathic, non"narcotic, non"addictive, over"the"counter pain reliever to treat moderate to severe chronic pain in companion animals; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxury Feet, an OTC pain reliever for foot pain from high heels and stilettos. It is also involved in developing RPI-78M to treat neurological and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, and general anti -viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Boca Raton, Florida.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
29 buys6 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| DEITSCH RIK Jtrack record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DEITSCH RIK Jtrack record | Buy | n/a (No price was disclosed in the filing) | conv 100First in 12mo | SEC |
| DEITSCH RIK Jtrack record | Buy | n/a (No price was disclosed in the filing) | conv 100First in 12mo | SEC |
| DEITSCH RIK Jtrack record | Buy | $100K | conv 50 | SEC |
| DEITSCH RIK Jtrack record | Award | $760K | Unusual size | SEC |
| DEITSCH RIK Jtrack record | Award | $40K | SEC |
| DEITSCH RIK Jtrack record | AwardD (derivative) | $390K | SEC |
| DEITSCH RIK Jtrack record | Buy | $150K | conv 42 | SEC |
| DEITSCH RIK Jtrack record | Buy | $150K | conv 67First in 12mo | SEC |
| DEITSCH RIK Jtrack record | Award | $121.7K | SEC |
| Lonky Stewart Alan | Award | n/a (No price was disclosed in the filing) | SEC |
| Lonky Stewart Alan | Other | $700 | SEC |
| POTTRUCK GARRY | Award | $110K | SEC |
| POTTRUCK GARRY | Award | $68.9K | SEC |
| POTTRUCK GARRY | Award | $57.5K | SEC |
| DEITSCH RIK Jtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 50 | SEC |
| DEITSCH RIK Jtrack record | Buy | $100K | conv 25 | SEC |
| Rumph Harold Henrytrack record | Award | $74K | SEC |
| DEITSCH RIK Jtrack record | Buy | $2K | conv 35 | SEC |
| DEITSCH RIK Jtrack record | Award | $150K | SEC |
| Rumph Harold Henrytrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 54Unusual sizeFirst in 12mo | SEC |
| Rumph Harold Henrytrack record | Sell | $156K | SEC |
| Rumph Harold Henrytrack record | Award | $80K | SEC |
| DEITSCH RIK Jtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 31 | SEC |
| Rumph Harold Henrytrack record | Award | $100K | SEC |